Pharmaceutical Marketing in India: Rules, Channels, Strategy

How pharmaceutical marketing works in India: UCPMP 2024 rules in plain English, which digital channels suit Rx, OTC and nutraceuticals, and what to measure.

Published 15 August 2026 by Web Hippo in Industry Insights

Pharmaceutical marketing in India runs on two tracks. Prescription (Rx) medicines are promoted to doctors, pharmacists and hospitals, through medical representatives, scientific content and continuing medical education. Over-the-counter (OTC) products and nutraceuticals can talk to consumers directly, much like any other brand, but with tighter limits on what they can claim.

Get the track wrong and a campaign can breach the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, the Drugs and Cosmetics Rules or the ad platforms' own policies. This guide explains the rules in plain English, maps which digital channels suit which product type, and covers medical representative (MR) enablement and measurement, with a revision box for B.Pharm students.

How Pharmaceutical Marketing Works in India

The product's legal category decides almost everything: who you may speak to, which channels you may use and what you may say. Most Indian pharma companies sell across more than one category, so a single marketing team often runs very different rulebooks side by side.

The Rx restriction comes from the Drugs and Cosmetics Rules, 1945. The conditions attached to manufacturing licences (for example Rules 74 and 78) state that no advertisement of drugs in Schedule H, Schedule H1 or Schedule X shall be made without the previous sanction of the Central Government. You can read this in the consolidated Act and Rules published by CDSCO. In practice, this is why you will not see brand-name antibiotic ads on Instagram in India.

Two more laws limit claims for every product type. Rule 106 and Schedule J of the same Rules list diseases a drug may not claim to prevent or cure, including diabetes, obesity, high or low blood pressure, cancer, baldness and "fairness of the skin". Separately, the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 prohibits advertisements for remedies that claim to treat diseases in its own schedule, or to improve sexual performance. These catch OTC and wellness brands that drift into cure claims.

What UCPMP 2024 Allows and Prohibits

The Department of Pharmaceuticals notified the UCPMP on 12 March 2024, replacing the 2015 version, and has amended it through circulars since. The latest consolidated text we checked is the UCPMP 2024 as amended up to 1 September 2025. Complaints go to an Ethics Committee for Pharma Marketing Practices at each industry association, with appeals to an apex committee headed by the Secretary of the Department. Here is what it means for marketers.

Three clauses matter more than most people expect for digital work. Clause 3.3 says paid promotional content must not look like editorial matter, which covers sponsored articles and "advertorial" posts. Clause 3.6 bans using HCPs' names or photographs in promotional material, which rules out the familiar "Dr X recommends" creative. And clause 4.5 says third parties working for a pharma company should know the code, so your agency is expected to understand it too.

Accountability sits at the top. The chief executive is responsible for adherence, and companies must file an annual disclosure of marketing expenditure, covering sample value and education programmes, within two months of the end of each financial year. Penalties include suspension or expulsion from the industry association, a public reprimand, a corrective statement in the same media and recovery of items given in breach.

Compliant Digital Channels for Pharma Marketing

Digital marketing for pharma companies is less about reach and more about reaching the right audience, with an audit trail. These are the channels we see work within the rules.

HCP portals and e-detailing

A gated portal for verified doctors, checked against their medical registration, is the backbone of digital Rx promotion. It can host product monographs, clinical summaries, dosing tools and recorded CMEs, all with the minimum prescribing information clause 3.2 requires. Keep the public pages of the same site free of Rx promotional claims; verification is what separates HCP communication from public advertising.

Medical content and SEO

Doctors search too, often for guideline updates, dosing in special populations or drug interactions. Well-referenced medical content, reviewed by your medical affairs team, builds authority with both doctors and Google. For patient-facing content, stick to condition education and avoid naming Rx brands. Our content marketing team works with client medical reviewers for exactly this reason.

Webinars and virtual CMEs

Virtual CMEs cut travel and hospitality questions out entirely, which makes them one of the cleanest formats under UCPMP. Keep the 1:10 speaker-to-participant ratio, document how speakers were chosen and disclose the spend on your website as clause 6 requires. Record sessions for the HCP portal so each one keeps working after the live date.

LinkedIn for B2B and corporate brand

LinkedIn suits the corporate side of pharma: API and CDMO business development, hospital procurement, investor relations and hiring MRs. It is not a place for Rx brand promotion, since your followers are the general public in the eyes of the law. Our guide to LinkedIn B2B lead generation in India covers the tactics.

Disease-awareness campaigns

Unbranded awareness campaigns, such as "know your HbA1c" or thyroid screening drives, can run for the public if they genuinely do not promote a product. Keep them free of brand names, brand colours and pack shots, and point people to "consult your doctor", not to a product. This is a grey area, so run every awareness creative past your legal team.

Consumer ads for OTC and wellness

OTC and nutraceutical brands can use search, social and e-commerce ads. Google's healthcare and medicines policy allows manufacturers to promote OTC medicines in India in line with local law, while online pharmacies need LegitScript certification plus Google certification and cannot promote prescription drugs. Meta's drugs and pharmaceuticals policy limits prescription drug ads to the US, Canada and New Zealand, and requires OTC ads to follow local law and exclude under-18s.

Channel × Product Type Compliance Matrix

This is the quick-reference grid we use when planning a pharma marketing strategy in India. "Allowed" still means allowed within the rules above, not anything goes.

Collecting doctors' and patients' contact details also brings in India's data protection law. Our DPDP compliance checklist for marketers explains consent notices and opt-outs.

Digital Enablement for Medical Representatives

MRs are still the core of Indian Rx promotion, and UCPMP clause 4 holds the company responsible for their conduct. Digital tools make MRs more useful to doctors and make compliance provable. In the teams we work with, these are the pieces that matter most:

Approved e-detailing decks on a tablet. One version of each deck, approved by medical and regulatory review, stops MRs making their own slides with unapproved claims.
Digital sample logs. Record doctor name, product, quantity and date at hand-over. Clause 5.1 requires these records, and a system can block the 13th pack of a drug to the same doctor in a year.
Remote detailing. Short scheduled video calls work well for busy specialists and doctors in tier-2 and tier-3 towns that MRs visit rarely.
Content follow-ups. After a visit, the MR sends a link to the relevant portal page through an approved, consent-based channel, not a forwarded PDF from a personal phone.
A clear gifts rule in the CRM. Only brand reminder items on an approved list, valued under ₹1,000, can be logged for distribution.

A Worked Example: Launching an Rx Diabetes Brand

Say a Hyderabad-based mid-size company is launching a new metformin combination across Telangana and Andhra Pradesh, targeting 500 physicians and diabetologists. This is an illustrative plan, not a client case.

Notice how much of the plan is decided by the rules before any creative work starts. That is normal in pharma, and it is why we'd always bring the regulatory team into the first planning meeting rather than the final sign-off.

How to Measure Pharma Marketing

You cannot track prescriptions the way an e-commerce brand tracks sales, so measurement leans on leading indicators. We'd track these, reviewed monthly:

Verified HCP reach: portal registrations checked against medical registration, split by specialty and territory.
Engagement depth: repeat visits, content completion and CME attendance per doctor, not page views.
MR productivity: calls per day, share of calls with a digital follow-up, and remote versus in-person split.
Prescription trends: third-party prescription and retail audit data, compared across territories with and without a campaign.
For OTC and nutraceuticals: the usual consumer metrics, such as cost per acquisition, marketplace rank and branded search volume.

Common Mistakes in Pharma Marketing

Posting or boosting Rx brands on social media. A public company page speaks to the public, so an Rx product post there is public promotion, and boosting it only widens the reach.
"Doctor recommended" creatives with a real doctor's photo. Clause 3.6 bans HCP names and photos in promotional material.
Cure claims on wellness products. A supplement that "reverses diabetes" breaches Schedule J and invites action under the Drugs and Magic Remedies Act.
Unreviewed MR WhatsApp messages. Forwarded images with unapproved claims are still company promotion.
Conference "delegate packages". Paying travel or hotels for non-speaking doctors breaches clauses 8.2 and 8.3.

Key Concepts for Pharma Marketing Management Students

If you are studying pharma marketing management for a B.Pharm or MBA exam, these are the terms that come up most often, explained in one line each.

For how clinics and hospitals market themselves, which is a different set of rules, see our guide to digital marketing for healthcare in India and our healthcare marketing services.

Frequently Asked Questions

Planning an OTC launch, an HCP portal or MR enablement? Talk to our team about a compliance-first plan.

Last checked September 2026 against the UCPMP 2024 as amended to 1 September 2025, the Drugs and Cosmetics Rules text published by CDSCO, and Google and Meta ad policies. Rules change; confirm current versions with your regulatory team before acting. Not legal advice.